- scuttleblurb - https://www.scuttleblurb.com -

[scuttlebit] Thermo Fisher update

Posted By scuttleblurb On In scuttlebits,[TMO] Thermo Fisher | Comments Disabled

MBI and I recorded an episode of Never Sell recently (AI Doom, Veeva, Research and Writing) (Spotify, Apple, YouTube, RSS feed) Upcoming posts (in no particular order): Upwork, Adyen, PayPal, Gartner, Verisk, maybe Visa/Mastercard As discussed in last week’s scuttlebit, Danaher’s life sciences coverage can basically be boiled down to 3 types of products: 1) diagnostic instruments and assays that hospitals […]

To access this post, you must purchase Annual subscription [1], Quarterly subscription [2] or Monthly subscription [3].

[scuttlebit] Danaher update

Posted By scuttleblurb On In [DHR] Danaher | Comments Disabled

It’s been nearly three years since I last wrote up Danaher and Thermo Fisher, so I figure it’s time for an update, especially with both companies announcing huge acquisitions recently. Let’s start with Danaher, specifically its Diagnostics division, which sells instruments and associated consumables that hospitals use to diagnose diseases. Though accounting for 41% of […]

To access this post, you must purchase Annual subscription [1], Quarterly subscription [2] or Monthly subscription [3].

[RYAN] Ryan Specialty – the middlemen have middlemen

Posted By scuttleblurb On In [RYAN] Ryan Specialty | Comments Disabled

This is a companion piece to the Kinsale writeup from a few weeks ago, where I explained some of the key differences between admitted and non-admitted insurance. Basically, admitted insurance covers familiar risks with well-understood parameters that are underwritten in huge volume, like standard home and auto. Non-admitted (or “excess & surplus”) insurance addresses quirkier, […]

To access this post, you must purchase Annual subscription [1], Quarterly subscription [2] or Monthly subscription [3].

S&P, Moody’s, and the limits of AI disruption: Part 2

Posted By scuttleblurb On In [MCO] Moody's Corp | Comments Disabled

I briefly discussed credit ratings in my S&P write-up. It’s a great business, we all know that. But it’s also tied to issuance volume, which is highly cyclical and difficult to predict. Investors tend to dislike that kind of volatility even in deeply moated companies. Perhaps in an effort to smooth its earnings profile through […]

To access this post, you must purchase Annual subscription [1], Quarterly subscription [2] or Monthly subscription [3].

[scuttlebit] Wix at the AI Crossroads

Posted By scuttleblurb On In [WIX] Wix.com | Comments Disabled

What are scuttlebits? Wix was conceived to democratize the creation of websites at a time when doing so required access to developers. Its Wix Editor presented a drag-and-drop interface that let anyone arrange design elements into a professional-looking web presence, no code required. Over time, Wix expanded beyond well site design, adding capabilities – accepting […]

To access this post, you must purchase Annual subscription [1], Quarterly subscription [2] or Monthly subscription [3].

S&P, Moody’s, and the limits of AI disruption: Part 1

Posted By scuttleblurb On In [SPGI] S&P Global | Comments Disabled

(Part 1 concerns S&P Global; Part 2 will be published next week and discusses Moody’s) Moody’s and S&P Global have this year traded as a blended average of two different businesses: a deeply moated ratings franchise that is largely insulated from AI disruption, and a data and analytics operation that is squarely in its crosshairs. […]

To access this post, you must purchase Annual subscription [1], Quarterly subscription [2] or Monthly subscription [3].

Veeva, AI, and regulated workflows

Posted By scuttleblurb On In [VEEV] Veeva Systems | Comments Disabled

I recently recorded my annual podcast interview with @LibertyRPF, where I offer some thoughts on the market and the business of newsletters. Enjoy! (Spotify, Apple, YouTube) A lot has happend since I wrote up Veeva nearly five years ago. At the time, Veeva, the dominant biopharma CRM, remained locked in a bitter dispute with IQVIA, […]

To access this post, you must purchase Annual subscription [1], Quarterly subscription [2] or Monthly subscription [3].

How Pool stacks up to Watsco

Posted By scuttleblurb On In [POOL] Pool Corp. | Comments Disabled

MBI and I recorded an episode of Never Sell recently (Big Tech Earnings) (Spotify, Apple, YouTube, RSS feed) Having just written up Watsco, I thought I’d offer some thoughts on revisit Pool Corp. given the similarities between the two businesses. Pool Corp is a distributor of pool supplies and equipment. It sources ~200k SKUs from 2k+ suppliers and sells them to […]

To access this post, you must purchase Annual subscription [1], Quarterly subscription [2] or Monthly subscription [3].